BIASIOLO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.504
EU - Europa 802
AS - Asia 586
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.501
CN - Cina 480
FI - Finlandia 173
DE - Germania 143
SE - Svezia 143
IT - Italia 142
UA - Ucraina 85
GB - Regno Unito 72
VN - Vietnam 54
IN - India 47
IE - Irlanda 15
FR - Francia 7
NL - Olanda 6
BG - Bulgaria 3
CA - Canada 3
ES - Italia 3
RO - Romania 3
AU - Australia 2
HK - Hong Kong 2
PL - Polonia 2
AT - Austria 1
BE - Belgio 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RU - Federazione Russa 1
SG - Singapore 1
SI - Slovenia 1
Totale 6.896
Salva come PNG Salva come JPEG
Città #
Fairfield 787
Chandler 577
Jacksonville 488
Woodbridge 476
Houston 413
Ashburn 363
Wilmington 337
Cambridge 316
Ann Arbor 310
Seattle 272
Princeton 161
Beijing 95
San Diego 91
Helsinki 83
Nanjing 83
Padova 79
Des Moines 75
Medford 73
Roxbury 60
Dong Ket 54
Boardman 52
Dearborn 45
Guangzhou 38
Pune 36
Shenyang 35
Changsha 24
Jinan 24
Hebei 23
Nanchang 23
Falls Church 20
Norwalk 16
Dublin 15
Hefei 14
London 14
Detroit 13
Jiaxing 13
Kunming 13
Tianjin 9
Bologna 7
Shanghai 7
Zhengzhou 7
New York 6
Paris 6
Redwood City 6
Tappahannock 6
Haikou 5
Milan 5
Ningbo 5
Ogden 5
Chengdu 4
Chicago 4
Frankfurt am Main 4
Fuzhou 4
Indiana 4
Kharkiv 4
Pesaro 4
Phoenix 4
Rockville 4
Wuhan 4
Baotou 3
Borås 3
Lanzhou 3
Mamoiada 3
Nürnberg 3
Sofia 3
Venezia 3
Amsterdam 2
Auburn Hills 2
Campodarsego 2
Chiswick 2
Gubbio 2
Hanover 2
Hong Kong 2
Hounslow 2
Kilburn 2
Legnaro 2
Mestre 2
Munich 2
Naples 2
New Bedfont 2
Prescot 2
Quzhou 2
Redmond 2
Shaoxing 2
Simi Valley 2
Washington 2
Xian 2
Aigaleo 1
Arezzo 1
Brisbane 1
Brussels 1
Changchun 1
Council Bluffs 1
Edinburgh 1
Falkenstein 1
Fostoria 1
Genoa 1
Groningen 1
Grottammare 1
Guiyang 1
Totale 5.801
Salva come PNG Salva come JPEG
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 178
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 172
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 145
APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. 131
A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses 111
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS 109
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 104
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome 102
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma 102
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study 102
PURIFICATION OF ANTICARDIOLIPIN AND LUPUS ANTICOAGULANT ACTIVITIES BY USING CARDIOLIPIN IMMOBILIZED ON AGAROSE BEADS 100
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 100
ANTIPHOSPHOLIPID ANTIBODIES ARE NOT PRESENT IN THE MEMBRANE OF GEL-FILTERED PLATELETS OF PATIENTS WITH IGG ANTICARDIOLIPIN ANTIBODIES, LUPUS ANTICOAGULANT AND THROMBOSIS 98
BINDING OF AUTOIMMUNE CARDIOLIPIN-REACTIVE ANTIBODIES TO HEPARIN - A MECHANISM OF THROMBOSIS 97
Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma 94
Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome 93
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 93
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 91
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 91
A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants 87
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. 87
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 87
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 87
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 86
A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation 86
Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface 85
Purification of anticardiolipin and lupus anticoagulant activities by using cardiolipin immobilized on agarose beads. 85
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. 84
Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins 82
Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis 82
A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment 80
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 78
SERPINB3 delays glomerulonephritis and attenuates the lupus-like disease in lupus murine models by inducing a more tolerogenic immune phenotype 78
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 77
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 76
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 75
A comparison of lupus anticoagulant-positive patients with clinical picture of Antiphospholipid syndrome and those without 73
[Anti-beta(2) glycoprotein I beta(2) glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases 71
REVERSAL OF EXCESSIVE EFFECT OF REGULAR ANTICOAGULATION - LOW ORAL DOSE OF PHYTONADIONE (VITAMIN-K1) COMPARED WITH WARFARIN DISCONTINUATION 70
SCCA-IGM USEFULNESS TO MONITOR PATIENTS WITH CIRRHOSIS IS NOT AFFECTED BY INTERFERING IGM'S 69
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 69
Serpinb3 is overexpressed in the liver in presence of iron overload 68
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 68
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 67
Mechanical prosthetic heart valve thrombosis despite optimal anticoagulation in a patient with congenital thrombophilia (factor V Leiden) 66
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 66
COMBINING SCCA-IGM AND AFP-IGM LEVELS INCREASES ACCURACY OF HEPATOCELLULAR CARCINOMA DETECTION 66
Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity 64
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 64
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 62
Low intensity warfarin therapy. 61
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers 61
SERPINB3 is associated with longer survival in transgenic mice. 61
Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic anticoagulant therapy: a prospective multicenter study 60
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 59
[IgG anti-beta 2-glycoprotein I beta 2-glycoprotein I] immune complexes in patients with antiphospholipid (aPL) syndrome 58
Effect of anti-beta-2-glycoprotein I Lupus Anticoagulants on fibrin polymerization and fibrinolysis 58
EVALUATION OF THE ANALYTICAL SPECIFICITY OF SCCA-IGM ASSAY FOR MONITORING PATIENTS WITH CIRRHOSIS 58
SERPINB3 modulates TGF-beta expression in chronic liver disease. 57
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 57
SCCA1-IGM AND SCCA2-IGM COMPARED WITH TOTAL SCCA-IGM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 56
CIRCULATING SURVIVIN-IGM IS A NOVEL CANDIDATE BIOMARKER OF CIRRHOSIS AND INCREASES WITH CHILD SCORE IN PATIENTS AFFECTED BY LIVER DISEASES 56
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 55
Anti phospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purifled IgG with anticardiolipin and anti-beta 2-glycoprotein I activity 54
Initiation of warfarin treatment in outpatients with nonrheumatic atrial fibrillation: a scheme for early prediction of maintenance dose 53
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 53
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 53
Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients 53
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 51
Autoimmune antiphospholipid antibodies: What is their true target? 50
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 48
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of a portable prothombin time monitor (Coagucheck) 48
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma 48
The risk of overdiagnosis of antiphospholipid syndrome 46
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 46
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 45
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 45
HEPATOCELLULAR CARCINOMA INDUCES SPECIFIC IGM-BIOMARKERS IMMUNE COMPLEXES 45
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 44
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 43
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 43
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 43
Serum and bile squamous cell carcinoma antigen 1 (SCCA1) detection: a new diagnostic approach in patients with perihilar cholangiocarcinoma (pCCA) 41
OSTEOPONTIN-IGM IN THE DIAGNOSIS OF HCC 39
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 38
DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA 38
Engineered EVs for oxidative stress protection 38
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 38
Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. 37
Effect of anti beta2-glycoprotein I Lupus Anticoagulant antibodies on clotting time in the presence of human umbilical vein endothelial cells 35
VASCULAR ENDOTELIAL GROWTH FACTOR (VEGF)- IgM COMPLEX FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 35
MATRIX METALLOPROTEINASE 9 (MMP9)-IgM COMPLEX: AN EMERGING NOVEL BIOMARKER IN COLORECTAL CANCER 33
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 32
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 32
SERPINB3 IS ASSOCIATED TO LONGER SERVIVAL IN MALE TRANSGENIC MICE 31
IMPROVED DETECTION OF HCC BY CO-DETERMINATION OF IgM ANTI-AFP ANTIBODIES AND AFP-IgM IMUNE COMPLEXES 31
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 29
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 28
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA)-IgM COMPLEX: SCCA1-IgM and SCCA2-IgM COMPARED TO TOTAL SCCA-IgM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 27
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 27
Totale 6.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.690
article - articoli 19.388
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 316
Totale 42.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019487 0 0 0 0 0 0 0 0 0 105 195 187
2019/20201.666 214 56 23 166 142 142 228 194 159 192 71 79
2020/20211.075 45 63 30 89 20 95 24 85 175 178 136 135
2021/20221.151 20 151 106 99 57 78 59 103 74 17 126 261
2022/20231.148 239 122 61 115 177 165 6 72 131 11 35 14
2023/2024432 22 98 64 36 44 79 38 27 12 12 0 0
Totale 6.943